fingolimod hydrochloride has been researched along with busulfan in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (busulfan) | Trials (busulfan) | Recent Studies (post-2010) (busulfan) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 4,967 | 645 | 1,426 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | busulfan (IC50) |
|---|---|---|---|
| Matrix metalloproteinase-9 | Homo sapiens (human) | 5.215 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isaka, Y; Li, XK; Liu, C; Nagahara, Y; Saito, T; Zhu, P; Zhuang, J | 1 |
1 other study(ies) available for fingolimod hydrochloride and busulfan
| Article | Year |
|---|---|
Non-myeloablative conditioning is sufficient to induce mixed chimerism and subsequent acceptance of donor specific cardiac and skin grafts.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Cell Count; Fingolimod Hydrochloride; Graft Survival; Green Fluorescent Proteins; Heart Transplantation; HLA-B27 Antigen; Immunosuppressive Agents; Leukocytes; Myeloablative Agonists; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Transgenic; Skin Transplantation; Sphingosine; T-Lymphocytes, Regulatory; Transplantation Chimera; Transplantation Conditioning | 2013 |